47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 0,2 | -∞ |
Gross profit (loss) | 0 | 0,2 | -∞ |
EBITDA | 0 | 0,2 | -∞ |
Short time liabilities | 0 | 1,3 | -∞ |
Other operating costs | 0 | 0 | -∞ |
Equity capital | 0 | 1,1 | -∞ |
Operating profit (EBIT) | 0 | 0,2 | -∞ |
Assets | 0 | 2,4 | -∞ |
Net profit (loss) | 0 | 0,2 | -∞ |
Cash | 0 | 0,1 | -∞ |
Liabilities and provisions for liabilities | 0 | 1,3 | -∞ |
Net income from sale | 0 | 3,2 | -∞ |
Working assets | 0 | 2,4 | -∞ |
Other income costs | 0 | 0 | -∞ |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | 15,6 | ||
Equity capital to total assets | 46,4 | ||
Gross profit margin | 5,4 | ||
EBITDA Margin | 5 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 144 | 144 |
Current financial liquidity indicator | 1.8991411924362183 | ||
Net dept to EBITDA | -0.8075353503227234 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane